Unicharm (UNICY) AI Stock Analysis

• Market Cap: $12.80B
• Dividend Yield: 0.48%
• Average Volume (3M): 46.38K
• Price to Earnings (P/E): 22.5
• Beta (1Y): 0.14
• Revenue Growth: -2.91%
• EPS Growth: -2.64%
• Country: US
• Employees: 1,404
• Sector: Consumer Defensive
• Sector Strength: 53
• Industry: Household & Personal Products
• EPS (TTM): 0.03
• Shares Outstanding: 3,725,005,900
• 10 Day Avg. Volume: 58,859
• 30 Day Avg. Volume: 46,383
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.90
• Enterprise Value/Revenue: 0.01
• Enterprise Value/Gross Profit: 0.03
• Enterprise Value/Ebitda: 0.06
• 1Y Price Target: $4.50
• Price Target Upside: 25.70% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 62 Neutral
• Price Target: $3.50 ▼(-2.23% Downside)

Unicharm's stock score is strongly supported by its robust financial performance, reflecting solid revenue growth and profitability. However, bearish technical indicators and a moderate valuation score weigh down the overall score. The lack of recent earnings call data and corporate events does not impact the score.

Unicharm Business Overview & Revenue Model

Company Description

Unicharm Corporation engages in the manufacture and sale of baby and childcare, feminine care, health care, cosmetic, household, and pet care products in Japan and internationally. Its baby and child care products, including disposable diapers and baby wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; and feminine care products comprise napkins, tampons, panty liners, sanitary short, and other feminine care products under the Sofy, Center-In, and Unicharm brands. The company's wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand; and masks under the Unicharm brands. It also provides home care products, including cleaning sheets under the Wave brand; cosmetic cotton and wet wipes under the Silcot brand; and paper towels under the Cook Up brand. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Grand Deli, Best Balance, Physicalife Dog, Silver Plate, Manner Wear, Deo Sheet, Silver Spoon, AllWell, Physicalife Cat, Deo Toilet, Deo Sand, Deo Clean, Aiken Genki, and Neko Genki brands. Further, it is involved in the manufacture and sale of industrial materials, food-packaging materials, etc. The company was incorporated in 1941 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Unicharm generates revenue primarily through the sale of its personal care products, which are marketed under several well-known brand names. The company's revenue streams are diversified across its key product categories: baby care, feminine care, health care, and pet care. Baby care products, such as disposable diapers, constitute a significant portion of their income, especially in emerging markets with high birth rates. Feminine care products, including sanitary napkins, contribute notably to revenue, driven by strong demand and brand loyalty. Additionally, adult incontinence products are an important growth area due to aging populations globally. Pet care products also form a significant revenue stream as pet ownership increases worldwide. The company leverages a robust distribution network and strategic partnerships with retailers and distributors to ensure its products reach a wide consumer base. Unicharm's focus on innovation and sustainability enhances its competitive edge, enabling it to maintain strong market positions and profitability.

Unicharm Financial Statement Overview

Summary

Unicharm presents a strong financial position overall, characterized by robust revenue growth, improved profitability, and solid cash flow generation. The company's leverage is well-managed, though a vigilant approach towards growing liabilities is advised.

Income Statement

Unicharm has shown strong revenue growth with a consistent upward trajectory from 2020 to 2025. The gross profit margin remains robust, indicating effective cost management. Net profit margin has improved over the years, showcasing enhanced profitability. The EBIT and EBITDA margins reflect solid operational efficiency. Overall, the income statement reflects strong revenue growth and improved profitability, with effective cost controls and operational efficiency.

Balance Sheet

The company's balance sheet is stable with a healthy debt-to-equity ratio that indicates controlled leverage. The return on equity shows improvement, evidencing effective use of shareholder funds. The equity ratio remains solid, signifying financial stability. However, the slight increase in total liabilities should be monitored. Overall, the balance sheet demonstrates strong equity and financial stability, although there's a need to keep an eye on growing liabilities.

Cash Flow

Unicharm's cash flow statements reveal a positive trend in operating cash flow, aligning well with net income. The free cash flow shows consistent growth, reflecting strong cash generation capabilities. The free cash flow to net income ratio is favorable, indicating efficient cash use. Overall, strong cash flow generation supports financial health, though slight fluctuations in free cash flow growth require attention.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	988.98B	941.79B	898.02B	782.72B	727.48B
Gross Profit	389.91B	351.53B	328.60B	313.64B	292.61B
EBITDA	191.02B	180.56B	161.16B	160.80B	147.56B
Net Income	81.84B	86.05B	67.61B	72.75B	52.34B
Balance Sheet
Total Assets	1.24T	1.13T	1.05T	987.65B	893.41B
Cash, Cash Equivalents and Short-Term Investments	368.75B	253.77B	307.60B	307.30B	297.11B
Total Debt	26.85B	28.57B	27.02B	38.31B	33.18B
Total Liabilities	366.26B	345.38B	340.61B	352.22B	330.76B
Stockholders Equity	773.06B	695.72B	618.88B	557.64B	493.00B
Cash Flow
Free Cash Flow	97.77B	124.00B	59.27B	70.58B	114.75B
Operating Cash Flow	137.10B	162.41B	92.22B	105.25B	150.25B
Investing Cash Flow	-73.84B	-67.53B	-7.14B	-79.84B	-41.70B
Financing Cash Flow	-66.79B	-67.01B	-61.65B	-45.18B	-35.24B

Unicharm Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.58
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UNICY, the sentiment is Negative. The current price of 3.58 is above the 20-day moving average (MA) of 3.49, below the 50-day MA of 3.69, and below the 200-day MA of 4.12, indicating a neutral trend. The MACD of -0.04 indicates Negative momentum. The RSI at 45.49 is Neutral, neither overbought nor oversold. The STOCH value of 82.41 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UNICY.

Unicharm Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PG	73 Outperform	$353.21B	23.15	31.15%	2.74%	0.29%	7.86%
UL	73 Outperform	$146.95B	24.56	28.36%	3.21%	-0.30%	-14.60%
KVUE	71 Outperform	$41.45B	39.37	10.22%	3.80%	-1.18%	-29.18%
KMB	70 Neutral	$43.35B	18.01	196.26%	3.80%	-6.89%	7.52%
CL	63 Neutral	$0.00	23.43	705.21%	2.46%	0.05%	3.55%
UNICY	62 Neutral	$12.80B	22.45	11.28%	0.48%	-2.91%	-2.64%
Sector *	50 Neutral	AU$2.04B	-0.17	-22.96%	9.17%	4.40%	-101.77%